An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells by Ivan Zanoni, Yunhao Tan, Marco Di Gioia, Achille Broggi, Jianbin.

Slides:



Advertisements
Similar presentations
An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis  Li-Wen Liu, Tomoyuki Nishikawa,
Advertisements

Volume 20, Issue 4, Pages (July 2017)
Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
IFN-γ Primes Keratinocytes for HSV-1–Induced Inflammasome Activation
CLEC5A is critical for dengue virus–induced inflammasome activation in human macrophages by Ming-Fang Wu, Szu-Ting Chen, An-Hang Yang, Wan-Wan Lin, Yi-Ling.
Volume 133, Issue 5, Pages (November 2007)
Volume 9, Issue 5, Pages (December 2014)
by Alexander Kiani, Francisco J
Volume 28, Issue 2, Pages (February 2008)
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 45, Issue 5, Pages (November 2016)
Volume 31, Issue 2, Pages (August 2009)
Inflammasome responses.
Volume 8, Issue 6, Pages (December 2010)
LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia by Hongwei Qin, Cynthia A. Wilson, Sun Jung Lee,
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Volume 38, Issue 4, Pages (April 2013)
PVSRIPO-mediated APC activation occurs in immunosuppressive conditions
Fig. 3 BX795 blocks the synthesis of HSV-1 virions.
Volume 35, Issue 6, Pages (December 2011)
Allergy-Inducing Chromium Compounds Trigger Potent Innate Immune Stimulation Via ROS-Dependent Inflammasome Activation  Christian Adam, Jonas Wohlfarth,
Volume 20, Issue 3, Pages (September 2016)
Integrin α5β1 Activates the NLRP3 Inflammasome by Direct Interaction with a Bacterial Surface Protein  Hye-Kyoung Jun, Sung-Hoon Lee, Hae-Ri Lee, Bong-Kyu.
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 4, Issue 4, Pages (October 2008)
Volume 6, Issue 6, Pages (March 2014)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 48, Issue 1, Pages e6 (January 2018)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Volume 25, Issue 1, Pages (January 2014)
Volume 36, Issue 3, Pages (March 2012)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
3-Methyl-4-nitrophenol triggers nasal allergy by modulating dendritic cell properties  Xiao-Yu Liu, PhD, Yong-Jin Wu, MD, PhD, Li-Juan Song, MD, Xian-Hai.
Volume 47, Issue 4, Pages e3 (October 2017)
HRTV and SFTSV NSs, but not UUKV NSs, inhibits JAK/STAT IFN signaling.
LPS-induced caspase-11 processing is independent of the NLRP3 and caspase-1 inflammasome. LPS-induced caspase-11 processing is independent of the NLRP3.
Volume 12, Issue 1, Pages (July 2015)
Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock  Dahai Yang, Yuan He, Raul Muñoz-Planillo,
Daniel B. Stetson, Ruslan Medzhitov  Immunity 
Active Caspase-1 Is a Regulator of Unconventional Protein Secretion
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 34, Issue 3, Pages (March 2011)
Volume 69, Issue 3, Pages e5 (February 2018)
Fig. 4 TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV release in murine MSCs. TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV.
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 32, Issue 5, Pages (May 2010)
Volume 24, Issue 3, Pages (March 2006)
Volume 34, Issue 2, Pages (February 2011)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 26, Issue 2, Pages e5 (January 2019)
Volume 42, Issue 4, Pages (April 2015)
Volume 22, Issue 6, Pages (February 2018)
Volume 42, Issue 1, Pages (January 2015)
Human Monocytes Engage an Alternative Inflammasome Pathway
Murine gingival MSCs and skin MSCs produce and secrete IL-1RA–EV
Figure 2 Glatiramer acetate treatment induced M2 differentiation through a MyD88-independent pathway (A) As described previously,3 M2 monocytes were treated.
Fig. 2. Spontaneous inflammasome activation by pyrin S242R.
Volume 32, Issue 1, Pages (January 2010)
Volume 7, Issue 5, Pages (May 2010)
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 16, Issue 16, Pages (August 2006)
Volume 31, Issue 6, Pages (December 2009)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Genetic Targeting of the Active Transcription Factor XBP1s to Dendritic Cells Potentiates Vaccine-induced Prophylactic and Therapeutic Antitumor Immunity 
Volume 156, Issue 4, Pages (February 2014)
Volume 16, Issue 7, Pages (August 2016)
Sean P. Cullen, Conor J. Kearney, Danielle M. Clancy, Seamus J. Martin 
Volume 25, Issue 3, Pages (September 2006)
Volume 21, Issue 1, Pages (January 2017)
Presentation transcript:

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells by Ivan Zanoni, Yunhao Tan, Marco Di Gioia, Achille Broggi, Jianbin Ruan, Jianjin Shi, Carlos A. Donado, Feng Shao, Hao Wu, James R. Springstead, and Jonathan C. Kagan Science Volume 352(6290):1232-1236 June 3, 2016 Published by AAAS

Fig. 1 oxPAPC does not induce TLR4 signaling. oxPAPC does not induce TLR4 signaling. (A) MΦs or DCs were treated with LPS or oxPAPC for the indicated time points. TLR4 dimerization and endocytosis were measured by flow cytometry. The line graphs represent means and standard deviations (SDs) of four replicates. (B) MΦs or DCs were treated with LPS or oxPAPC. Cytokine production was analyzed 18 hours later. Means and SDs of four replicates are shown. (C) Myddosome formation in iMΦs was assessed at the indicated time points after treatment with LPS or oxPAPC by coimmunoprecipitation (IP) of IRAK4 with MyD88 followed by Western analysis of the proteins indicated. (D) Whole-cell lysates (WCL) were collected and DCs were monitored for STAT-1 phosphorylation and viperin expression after treatment with LPS oxPAPC. [(C) and (D)] One experiment representative of three is shown. Ivan Zanoni et al. Science 2016;352:1232-1236 Published by AAAS

Fig. 2 oxPAPC induces the activation of the NLRP3 inflammasome in DCs. oxPAPC induces the activation of the NLRP3 inflammasome in DCs. (A) DCs primed with LPS, followed by ATP or oxPAPC treatment. Cell culture supernatant from DCs subjected to indicated treatments was collected, and processed IL-1β (p17) production was assessed. One experiment representative of three is shown. (B) DCs were treated with LPS alone; were treated with 10, 50, or 120 μM of oxPAPC; or were primed with LPS for 3 hours and then treated with oxPAPC. For this experiment, commercially available oxPAPC and an oxPAPC enriched in PEIPC were used. Eighteen hours after LPS administration, secreted (left panel) and cell-associated (right panel) IL-1β was measured by enzyme-linked immunosorbent assay (ELISA). Means and SDs of four replicates are shown. (C) DCs of the genotypes indicated were treated with LPS alone, were treated with oxPAPC alone, or were primed with LPS for 3 hours and then treated with oxPAPC. Eighteen hours after LPS administration, IL-1β secretion was measured by ELISA. Means and SDs of four replicates are shown. (D) MΦs and DCs were treated with Pam3CSK (P3C) alone, were treated with oxPAPC alone, or were primed with Pam3CSK for 3 hours and then treated with oxPAPC, DOTAP alone, and LPS or oxPAPC encapsulated in DOTAP (N-[1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfate). Eighteen hours after P3C administration, IL-1β was measured by ELISA. Means and SDs of four replicates are shown. (E) DCs (left panel) or MΦs (right panel) were primed with LPS for 3 hours and treated with ATP. At indicated time points, IL-1β was measured by ELISA, and cell death was measured by propidium iodide permeabilization assay. Means and SDs of four replicates are shown. Ivan Zanoni et al. Science 2016;352:1232-1236 Published by AAAS

Fig. 3 oxPAPC promotes noncanonical inflammasome activation. oxPAPC promotes noncanonical inflammasome activation. (A) WT DC and caspase-11 KO DC were treated with LPS alone, were treated with oxPAPC alone, or were primed with LPS for 3 hours and then treated with oxPAPC. Eighteen hours after LPS administration, IL-1β secretion was measured by ELISA. Means and SDs of four replicates are shown. (B) DCs were left untreated or primed with LPS and then stimulated with ATP or oxPAPC. Specks containing ASC (green) and caspase-1 (Casp1, red) were analyzed 18 hours after LPS stimulation. Nuclei are shown in blue. Panels are representative of four independent experiments. Scale bar, 10 μm. (C) S100 fractions of nontreated (nt) or P3C-primed (P3C) MΦs were incubated with biotin-LPS (Bio-LPS), biotin-oxPAPC (Bio-oxPAPC), or biotin-MDP (Bio-MDP). Endogenous proteins associated with biotinylated ligands were captured by streptavidin beads and revealed by Western analysis. Shown is a representative blot out of three independent experiments. (D) SPR analysis of the interactions between the proteins and lipids indicated. (E) Gel filtration analysis of the size of caspase-11 complexes before and after exposure to oxPAPC. Complex size was monitored by A280 or Western analysis, as indicated. Shown is a representative blot out of three independent experiments. (F) Bone marrow cells were infected with the pMSCV2.2-IRES-GFP (internal ribosomal entry site–green fluorescent protein) vector (empty), the pMSCV2.2-IRES-GFP vector encoding WT caspase-11 (WT caspase-11), or the same vector containing a catalytic mutant caspase-11 (C254A). DCs were primed or not with LPS and then stimulated with oxPAPC, or transfected with LPS-containing FuGENE (Trans.LPS). Eighteen hours after LPS priming, supernatants were collected and IL-1β was measured by ELISA. Cell viability was assessed by measuring LDH release. Means and SDs of four replicates are shown. Ivan Zanoni et al. Science 2016;352:1232-1236 Published by AAAS

Fig. 4 oxPAPC prevents DC death and potentiates adaptive immune responses. oxPAPC prevents DC death and potentiates adaptive immune responses. (A and B) DCs were treated with LPS alone, ATP alone, oxPAPC alone or FuGENE-complexed LPS [Fugene (LPS)], or were primed for 3 hours with LPS and then treated with the indicated stimuli. Cell death was measured by LDH release (A), or IL-1β secretion was measured by ELISA (B). Means and SDs of four replicates are shown. (C and D) DCs were pretreated with LPS for 3 hours and then activated with ATP or oxPAPC. Eighteen hours later, cells were stained for ASC (green), nuclei (blue), (C) Zombie dye (red), or (D) active mitochondria (red). Scale bars, 10 μm. Panels are representative of three independent experiments. (E) CD4+ T cells were isolated from the draining lymph nodes 40 days after immunization with OVA + LPS in IFA (LPS), OVA + LPS + oxPAPC in IFA (LPS + oxPAPC), or OVA + oxPAPC in IFA (oxPAPC) of WT, caspase-1/-11 dKO, or caspase-11 KO mice. CD4+ T cells were restimulated or not with OVA in the presence of DCs. IFN-γ (left panel) and IL-17 (right panel) secretion was measured 5 days later by ELISA. Bar graphs represent means and standard errors of two experiments with five mice per group. *P < 0.05; **P < 0.01; ***P < 0.005. Ivan Zanoni et al. Science 2016;352:1232-1236 Published by AAAS